{"id":"W4241700116","doi":"10.1158/1538-7445.am2012-ct-04","title":"Abstract CT-04: A phase II study of neoadjuvant metformin in prostatic carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metformin; Prostate cancer; Tolerability; Prostatectomy; Adverse effect; Internal medicine; Urology; Cancer; Diabetes mellitus; Prostate; Oncology; Insulin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338243,0.001454888,0.001882923,0.0005705134,0.0005605723,0.0009927101,0.001204559,0.001159749,0.004781154],"category_scores_gemma":[0.0008364601,0.0006401071,0.0008400373,0.0006790694,0.001168,0.0009416129,0.0004052796,0.003146682,0.0009004904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008756037,"about_ca_system_score_gemma":0.002372393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001394766,"about_ca_topic_score_gemma":0.003360193,"domain_scores_codex":[0.9996372,0.0001980756,0.00002449819,0.00004292478,0.00003812166,0.00005905592],"domain_scores_gemma":[0.9992241,0.0001020087,0.000136772,0.00006139401,0.0000554965,0.0004202843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5897582,0.167168,0.01004253,0.002204333,0.001328055,0.000868562,0.000530714,0.003886254,0.1262924,0.0003929642,0.005105559,0.09242243],"study_design_scores_gemma":[0.2278009,0.7518607,0.00871967,0.00007171978,0.0002949279,0.0004630531,0.0001013404,0.0009223245,0.007231514,0.0001125507,0.002384557,0.00003665709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923879,0.001793714,0.0006263775,0.0003969829,0.0001126256,0.002572956,0.0006641546,0.0001017723,0.001343538],"genre_scores_gemma":[0.9866481,0.002073818,0.002002971,0.0007510522,0.0002068682,0.003244529,0.001594959,0.00003297855,0.00344463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004781154,"threshold_uncertainty_score":0.01599455,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0793018199902067,"score_gpt":0.4283110842525917,"score_spread":0.349009264262385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}